Gene: CIDEC
Official Full Name: cell death inducing DFFA like effector cprovided by HGNC
Gene Summary: This gene encodes a member of the cell death-inducing DNA fragmentation factor-like effector family. Members of this family play important roles in apoptosis. The encoded protein promotes lipid droplet formation in adipocytes and may mediate adipocyte apoptosis. This gene is regulated by insulin and its expression is positively correlated with insulin sensitivity. Mutations in this gene may contribute to insulin resistant diabetes. A pseudogene of this gene is located on the short arm of chromosome 3. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20788 | CIDEC Knockout cell line (A549) | Human | CIDEC | 1:3~1:4 | Negative | Online Inquiry |
CIDEC Gene Knockout Cell Lines are genetically engineered cell lines that have had the CIDEC (cell death-inducing DFFA-like effector c) gene selectively inactivated or "knocked out." This powerful tool allows researchers to study the function of CIDEC in a controlled environment, elucidating its role in critical biological processes such as adipocyte metabolism, apoptosis, and cellular differentiation. The mechanism of action revolves around CRISPR-Cas9 technology, which enables precise gene editing capabilities, ensuring that the targeted gene is accurately disrupted without affecting adjacent genes, thereby maintaining genomic integrity.
The scientific importance of CIDEC Gene Knockout Cell Lines lies in their application across various research domains, including metabolic diseases, obesity, and cancer studies. By using these knockout models, researchers can explore how the absence of CIDEC impacts cellular functions and contributes to disease pathology. In clinical settings, understanding the implications of CIDEC in metabolism may lead to novel therapeutic targets for metabolic syndrome or related disorders, making these tools vital for translational research.
CIDEC Gene Knockout Cell Lines present several advantages over alternative models, such as traditional knockdown methods. Unlike RNA interference that can produce inconsistent and temporary results, our knockout lines offer permanent gene inactivation, ensuring robust and reproducible experimental outcomes. Furthermore, these lines have been developed using validated techniques, providing end-users with confidence in the quality and reliability of their research findings.
For researchers and clinicians, the value of CIDEC Gene Knockout Cell Lines extends beyond basic science; they serve as essential tools for discovering novel insights and fostering innovative treatment strategies. By elucidating the role of CIDEC in health and disease, these cell lines will empower users to push the boundaries of knowledge in metabolic research.
Our company specializes in providing high-quality genetic tools tailored to the needs of the research community, showcasing our commitment to advancing scientific discovery. With years of expertise in genetic manipulation and a focus on delivering innovative products, we are your trusted partner in pioneering breakthroughs in biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.